OverviewSuggest Edit

Truveris is a health information technology company that provides management tools to sponsors of prescription benefit plans and payers of claims under these plans. The major prescription benefit sponsors/payers are governments (Federal, State & Local), health insurance companies, self-insured corporations, and unions. The Company's products and services allow these institutions to take control of ballooning pharmaceutical benefits costs, monitor and enforce Prescription Benefits Manager (PBM) contracts, and meet the regulatory compliance requirements of Sarbanes Oxley and Medicare Part D.
HQNew York, NY, US
Employee Ratings3.6
Overall CultureB-

Latest Updates

Employees (est.) (Jul 2021)153(-3%)
Job Openings23
Cybersecurity ratingBMore

Key People/Management at Truveris

Bryan Birch

Bryan Birch

Chairman, President and CEO - Current Investor
Jeff Eberle

Jeff Eberle

Chief Executive Officer
Leon Greene

Leon Greene

Co-Founder & Board Member
Mike Facendola

Mike Facendola

Chief Financial Officer
Nanette Oddo

Nanette Oddo

Chief Strategy Officer
Patrick Tyne

Patrick Tyne

Chief Product Officer
Show more

Truveris Office Locations

Truveris has an office in New York
New York, NY, US (HQ)
2 Park Ave 15th Floor
Show all (1)

Truveris Financials and Metrics

Summary Metrics

Founding Date


Truveris total Funding

$54 m

Truveris latest funding size

$25 m

Time since last funding

4 years ago

Truveris investors

Truveris's latest funding round in September 2017 was reported to be $25 m. In total, Truveris has raised $54 m
Show all financial metrics

Truveris Operating Metrics

Truveris's Customers was reported to be 350 in Sep, 2017.
Sep, 2017


Show all operating metrics

Truveris Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Truveris Online and Social Media Presence

Embed Graph

Truveris Company Culture

  • Overall Culture



  • CEO Rating



  • Compensation



Learn more on Comparably

Truveris Blogs

5 Misconceptions about Loss of Exclusivity that Impact Patient Retention

Loss of exclusivity can feel like a dramatic shift, forever changing a drug's profitability. However, this doesn't have to be your brand's fate.

The Impact of Recent State Legislation on Copay Accumulator Programs

Recently, several states have passed legislation that prohibits the use of copay accumulator adjustment programs. How does this affect your organization?

The Drug Formulary Formula: What You Need to Know to Choose the Right PBM

Understanding the ins and outs of drug formularies is essential to making an informed decision on which PBM to select for your members.

Generic Drug Differences and MAC Pricing: What Plan Sponsors Need to Know

Generic versions of brand name medications are not all the same. Understanding their differences and the MAC pricing implications is critical for choosing the most cost-effective PBM.

Webinar – Payer Strategies for Anticipating and Managing Gene Therapy

Join Truveris for a webinar on how Payers can best anticipate and manage new gene therapies.

What’s the Difference between a Specialty Drug and a Non-Specialty Drug?

Looking forward to the future of pharmacy, it’s critical to understand how a specialty drug is defined, how it differs from traditional, non-specialty drugs, and how specialty is impacting employers’ benefit plan designs.
Show more

Truveris Frequently Asked Questions

  • When was Truveris founded?

    Truveris was founded in 2009.

  • Who are Truveris key executives?

    Truveris's key executives are Bryan Birch, Jeff Eberle and Leon Greene.

  • How many employees does Truveris have?

    Truveris has 153 employees.

  • Who are Truveris competitors?

    Competitors of Truveris include Cecofar, Mcolson Research Labs and Oxford Pharmagenesis.

  • Where is Truveris headquarters?

    Truveris headquarters is located at 2 Park Ave 15th Floor, New York.

  • Where are Truveris offices?

    Truveris has an office in New York.

  • How many offices does Truveris have?

    Truveris has 1 office.